"Harmful, intrusive and humiliating," one advocate warned.

More physicians are discussing hormone replacement therapy with breast cancer survivors when menopause hits.

Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistenly managed, according to Nice ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.